178 related articles for article (PubMed ID: 36652552)
1. NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells.
Guan L; Nambiar DK; Cao H; Viswanathan V; Kwok S; Hui AB; Hou Y; Hildebrand R; von Eyben R; Holmes BJ; Zhao J; Kong CS; Wamsley N; Zhang W; Major MB; Seol SW; Sunwoo JB; Hayes DN; Diehn M; Le QT
Cancer Res; 2023 Mar; 83(6):861-874. PubMed ID: 36652552
[TBL] [Abstract][Full Text] [Related]
2. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
Benaiges E; Ceperuelo-Mallafré V; Guaita S; Maymó-Masip E; Madeira A; Gómez D; Hernández V; Vilaseca I; Merma C; León X; Terra X; Vendrell J; Avilés-Jurado FX; Fernández-Veledo S
Head Neck; 2024 Jul; 46(7):1752-1765. PubMed ID: 38305029
[TBL] [Abstract][Full Text] [Related]
3. NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma.
Hamad SH; Sellers RS; Wamsley N; Zolkind P; Schrank TP; Major MB; Weissman BE
Cancer Res Commun; 2024 Feb; 4(2):487-495. PubMed ID: 38335300
[TBL] [Abstract][Full Text] [Related]
4. TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.
Skinner HD; Sandulache VC; Ow TJ; Meyn RE; Yordy JS; Beadle BM; Fitzgerald AL; Giri U; Ang KK; Myers JN
Clin Cancer Res; 2012 Jan; 18(1):290-300. PubMed ID: 22090360
[TBL] [Abstract][Full Text] [Related]
5. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
6. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of radiosensitivity in head and neck squamous cell carcinoma.
Li G; Jiang Y; Li G; Qiao Q
Radiother Oncol; 2021 Jun; 159():126-135. PubMed ID: 33775714
[TBL] [Abstract][Full Text] [Related]
8.
Binkley MS; Jeon YJ; Nesselbush M; Moding EJ; Nabet BY; Almanza D; Kunder C; Stehr H; Yoo CH; Rhee S; Xiang M; Chabon JJ; Hamilton E; Kurtz DM; Gojenola L; Owen SG; Ko RB; Shin JH; Maxim PG; Lui NS; Backhus LM; Berry MF; Shrager JB; Ramchandran KJ; Padda SK; Das M; Neal JW; Wakelee HA; Alizadeh AA; Loo BW; Diehn M
Cancer Discov; 2020 Dec; 10(12):1826-1841. PubMed ID: 33071215
[TBL] [Abstract][Full Text] [Related]
9. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
10. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.
Oweida AJ; Darragh L; Phan A; Binder D; Bhatia S; Mueller A; Court BV; Milner D; Raben D; Woessner R; Heasley L; Nemenoff R; Clambey E; Karam SD
J Natl Cancer Inst; 2019 Dec; 111(12):1339-1349. PubMed ID: 30863843
[TBL] [Abstract][Full Text] [Related]
11. Radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma: biological angle.
Li CX; Gong ZC; Zhang WN; Zhang Y; Zhao HR
Oral Maxillofac Surg; 2024 Jun; 28(2):547-555. PubMed ID: 37935817
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of radioresistance in head and neck squamous cell carcinomas.
Avril D; Foy JP; Bouaoud J; Grégoire V; Saintigny P
Int J Radiat Biol; 2023; 99(4):583-593. PubMed ID: 35930497
[TBL] [Abstract][Full Text] [Related]
13. Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
Chen WC; Lai CH; Chuang HC; Lin PY; Chen MF
Head Neck; 2017 Feb; 39(2):347-355. PubMed ID: 27696591
[TBL] [Abstract][Full Text] [Related]
14. Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer.
Lang L; Chen F; Li Y; Shay C; Yang F; Dan H; Chen ZG; Saba NF; Teng Y
Cancer Res Commun; 2023 Apr; 3(4):659-671. PubMed ID: 37089864
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks.
Michna A; Schötz U; Selmansberger M; Zitzelsberger H; Lauber K; Unger K; Hess J
Radiat Oncol; 2016 Jul; 11():94. PubMed ID: 27455841
[TBL] [Abstract][Full Text] [Related]
16. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
Digomann D; Linge A; Dubrovska A
Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
[TBL] [Abstract][Full Text] [Related]
18. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
[TBL] [Abstract][Full Text] [Related]
19. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA BLACAT1 enhances radiosensitivity of head and neck squamous cell carcinoma cells by regulating PSEN1.
Gou C; Han P; Li J; Gao L; Ji X; Dong F; Su Q; Zhang Y; Liu X
Br J Radiol; 2020 Apr; 93(1108):20190154. PubMed ID: 31944856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]